Corning® ECM Mimetic Surfaces and Substrates | ECM Mimetic and Advanced Surfaces | Corning

We use cookies to ensure the best experience on our website.
View Cookie Policy
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

Obtain unique, functional surface activity to enable a range of specialized cell expansion and assay applications.

Support the propagation and differentiation of a wide range of stem, progenitor, and primary cell types with Corning® ECM Mimetic surfaces and substrates. Made with biologically active, synthetic, or recombinant animal-free peptides and proteins, our ECM mimetic and advanced surfaces enable optimal cell binding and signaling in a broad range of serum-free, xeno-free, and animal-free media formulations.

cGMP-compliant manufacturing and animal-free traceability — manufactured in animal-free, cGMP compliant facilities that meet ISO 9001:2008 and 13485:2012 standards using animal-free components, Corning ECM mimetic and recombinant laminin surfaces mitigate variability and risk of contamination from adventitious organisms common to animal-sourced material.

Scalable, pre-coated, room-temperature-stable vessel platforms — streamline the cell expansion workflow by removing the need for tedious, time consuming, and inconsistent self-coating protocols. Pre-coated recombinant laminin-521, Fibronectin peptide, Collagen I peptide, or Corning Synthemax® peptide surfaces are ready to use, stable and are available on multilayered vessels, such as the Falcon® Multi-Flask and Corning CellSTACK® vessels with closed system options.

Learn More About ECM Mimetic and Advanced Surfaces

Product Details

ECM Mimetic and Defined Surfaces Product Details and Applications

Innovation

Beyond Bisphosphonates: Inhibiting Bone Resorption Without Impacting Bone Rebuilding

Taking advantage of an advanced cell culture surface developed by Corning, scientists were able to identify cellular activity that revealed a deeper look into how osteoclasts work to facilitate bone resorption. Their research is providing vital information that may lead to the development of novel therapeutics offering advantages over treatments currently available for bone loss.

Learn More

Applications and Use

ECM Mimetic and Advanced Surfaces in Action

How to Choose, How to Use, & How to Buy

Related Products

Поделиться